Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
56.71
-0.38 (-0.67%)
Jun 30, 2026, 11:22 AM EDT - Market open
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $32.66 billion as of June 30, 2026. Its market cap has increased by 66.71% in one year.
Market Cap
32.66B
Enterprise Value
41.00B
1-Year Change
66.71%
Ranking
Category
Stock Price
$56.71
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from $26.49B to $32.66B, an increase of 23.25%. That is a compound annual growth rate of 3.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 32.66B | 46.41% |
| Dec 31, 2025 | 22.30B | 48.40% |
| Dec 31, 2024 | 15.03B | -10.44% |
| Dec 29, 2023 | 16.78B | -30.07% |
| Dec 30, 2022 | 24.00B | -0.82% |
| Dec 31, 2021 | 24.20B | -20.37% |
| Dec 31, 2020 | 30.39B | 14.69% |
| Jun 16, 2020 | 26.49B | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Regeneron Pharmaceuticals | 64.39B |
| argenx SE | 55.63B |
| Alnylam Pharmaceuticals | 38.90B |
| Revolution Medicines | 38.71B |
| BeOne Medicines AG | 31.12B |
| Moderna | 26.69B |
| Roivant Sciences | 24.51B |
| BioNTech SE | 23.07B |